Corporate Strategy
Page 1 • 2 itemsUnlock global pharma market insights. NovaPharmaNews delivers strategic intelligence for BD, investment, and M&A decisions.
Sun Pharma Acquires Organon for $11.75 Billion in Major Pharmaceutical Merger
Sun Pharmaceutical Industries announces $11.75 billion acquisition of Organon at $14 per share, creating global pharmaceutical powerhouse.
SBC Medical Group Holdings Prices 3.1 Million Share Secondary Offering at Market Rate
SBC Medical Group Holdings announces pricing of 3.1 million share secondary offering by major stockholder Dr. Yoshiyuki Aikawa in latest corporate move.